Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 21Active not recruiting 10Completed 5Not yet recruiting 4Terminated 3Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 18Leukemia, Myeloid, Acute 15Breast Neoplasms 14Glioblastoma 13Colorectal Neoplasms 13Prostatic Neoplasms 11Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Lung Neoplasms 9Glioma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 7Multiple Myeloma 7Head and Neck Neoplasms 7Carcinoma, Renal Cell 7Carcinoma, Hepatocellular 7Hematologic Neoplasms 6Triple Negative Breast Neoplasms 5Rectal Neoplasms 5Ovarian Neoplasms 5Melanoma 5Uterine Cervical Neoplasms 4Colonic Neoplasms 4Brain Neoplasms 4Solid Tumor 3Small Cell Lung Carcinoma 3Sarcoma 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

antineoplaston AS 2-1 1antineoplaston A10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Diffuse Intrinsic Pontine Glioma × 1 year × Clear all
NCT02742883 2025-09-16

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Burzynski Research Institute

Phase 2 Suspended
1 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡